Cargando…

1371. Identification of Risk Factors to Predict Gram negative bacteria in Patients with Upper Extremity Infections

BACKGROUND: Gram negative bacteria (GNB) have been identified as a cause of upper extremity infections and empiric treatment directed to both gram positive and negative organisms is often recommended. Risk-based approaches to establish need for gram-negative coverage may help to minimize unnecessary...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhitomirsky, Sophia, Sy, Hendrik, Yassin, Arsheena, Stavropoulos, Christine, Farkas, Andras
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644219/
http://dx.doi.org/10.1093/ofid/ofab466.1563
_version_ 1784610035290079232
author Zhitomirsky, Sophia
Sy, Hendrik
Yassin, Arsheena
Stavropoulos, Christine
Farkas, Andras
author_facet Zhitomirsky, Sophia
Sy, Hendrik
Yassin, Arsheena
Stavropoulos, Christine
Farkas, Andras
author_sort Zhitomirsky, Sophia
collection PubMed
description BACKGROUND: Gram negative bacteria (GNB) have been identified as a cause of upper extremity infections and empiric treatment directed to both gram positive and negative organisms is often recommended. Risk-based approaches to establish need for gram-negative coverage may help to minimize unnecessary drug exposure, but further information on such methods are currently lacking. The aim of this study was to identify risk factors associated with the isolation of GNB in patients with upper extremity infections. METHODS: We reviewed records of patients with upper extremity infections treated in two urban hospitals between March 2018 and July 2020. Prosthetic joint infections were excluded. Baseline demographic, clinical, surgical and microbiology data was collected. Multivariable logistic regression models were screened using Akaike Information Criterion to establish the best model and risk factors associated with isolation of a GNB. RESULTS: We identified 111 patients, the majority of whom were male with frequent history of IV drug use. Deep wound cultures in 30 (33.3%) individuals yielded a GNB, and 80% of these cases were polymicrobial. Among the GNB, most prevalent were Enterobacterales (10.4%), HACEK group (6.39%), and Pseudomonas spp. (4.5%) (Tables 1. and 2.). Infections were mostly limited to the soft tissue structures of the hand and the forearm, with involvements of the joint and bone being second and third most common. The final model identified the use of IV medications (OR 4.14, 95% CI 1.3 - 14.46) together with prior surgery at the site of infection within the last year (OR 5.56, 95% CI 1.06 - 30.98), and having an open wound on presentation (OR 3.03, 95% CI 1.04 - 9.47) as factors independently associated with isolation of a GNB (Table 3). AUROC of 0.702 indicates acceptable model discrimination. Table 1: Baseline characteristics [Image: see text] Table 2: Bacterial isolates [Image: see text] Table 3: Final model [Image: see text] CONCLUSION: Our logistic regression model identified significant predictors for isolation of GNB in upper extremity infections within this population. Results of this study will assist clinicians in making a better informed decision for the need of empiric gram negative coverage aimed to support the reduction of patient exposure to unnecessary antimicrobial coverage. External validation of the model is warranted prior to application to clinical care. Figure 1: AUROC [Image: see text] DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-8644219
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86442192021-12-06 1371. Identification of Risk Factors to Predict Gram negative bacteria in Patients with Upper Extremity Infections Zhitomirsky, Sophia Sy, Hendrik Yassin, Arsheena Stavropoulos, Christine Farkas, Andras Open Forum Infect Dis Poster Abstracts BACKGROUND: Gram negative bacteria (GNB) have been identified as a cause of upper extremity infections and empiric treatment directed to both gram positive and negative organisms is often recommended. Risk-based approaches to establish need for gram-negative coverage may help to minimize unnecessary drug exposure, but further information on such methods are currently lacking. The aim of this study was to identify risk factors associated with the isolation of GNB in patients with upper extremity infections. METHODS: We reviewed records of patients with upper extremity infections treated in two urban hospitals between March 2018 and July 2020. Prosthetic joint infections were excluded. Baseline demographic, clinical, surgical and microbiology data was collected. Multivariable logistic regression models were screened using Akaike Information Criterion to establish the best model and risk factors associated with isolation of a GNB. RESULTS: We identified 111 patients, the majority of whom were male with frequent history of IV drug use. Deep wound cultures in 30 (33.3%) individuals yielded a GNB, and 80% of these cases were polymicrobial. Among the GNB, most prevalent were Enterobacterales (10.4%), HACEK group (6.39%), and Pseudomonas spp. (4.5%) (Tables 1. and 2.). Infections were mostly limited to the soft tissue structures of the hand and the forearm, with involvements of the joint and bone being second and third most common. The final model identified the use of IV medications (OR 4.14, 95% CI 1.3 - 14.46) together with prior surgery at the site of infection within the last year (OR 5.56, 95% CI 1.06 - 30.98), and having an open wound on presentation (OR 3.03, 95% CI 1.04 - 9.47) as factors independently associated with isolation of a GNB (Table 3). AUROC of 0.702 indicates acceptable model discrimination. Table 1: Baseline characteristics [Image: see text] Table 2: Bacterial isolates [Image: see text] Table 3: Final model [Image: see text] CONCLUSION: Our logistic regression model identified significant predictors for isolation of GNB in upper extremity infections within this population. Results of this study will assist clinicians in making a better informed decision for the need of empiric gram negative coverage aimed to support the reduction of patient exposure to unnecessary antimicrobial coverage. External validation of the model is warranted prior to application to clinical care. Figure 1: AUROC [Image: see text] DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2021-12-04 /pmc/articles/PMC8644219/ http://dx.doi.org/10.1093/ofid/ofab466.1563 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Abstracts
Zhitomirsky, Sophia
Sy, Hendrik
Yassin, Arsheena
Stavropoulos, Christine
Farkas, Andras
1371. Identification of Risk Factors to Predict Gram negative bacteria in Patients with Upper Extremity Infections
title 1371. Identification of Risk Factors to Predict Gram negative bacteria in Patients with Upper Extremity Infections
title_full 1371. Identification of Risk Factors to Predict Gram negative bacteria in Patients with Upper Extremity Infections
title_fullStr 1371. Identification of Risk Factors to Predict Gram negative bacteria in Patients with Upper Extremity Infections
title_full_unstemmed 1371. Identification of Risk Factors to Predict Gram negative bacteria in Patients with Upper Extremity Infections
title_short 1371. Identification of Risk Factors to Predict Gram negative bacteria in Patients with Upper Extremity Infections
title_sort 1371. identification of risk factors to predict gram negative bacteria in patients with upper extremity infections
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644219/
http://dx.doi.org/10.1093/ofid/ofab466.1563
work_keys_str_mv AT zhitomirskysophia 1371identificationofriskfactorstopredictgramnegativebacteriainpatientswithupperextremityinfections
AT syhendrik 1371identificationofriskfactorstopredictgramnegativebacteriainpatientswithupperextremityinfections
AT yassinarsheena 1371identificationofriskfactorstopredictgramnegativebacteriainpatientswithupperextremityinfections
AT stavropouloschristine 1371identificationofriskfactorstopredictgramnegativebacteriainpatientswithupperextremityinfections
AT farkasandras 1371identificationofriskfactorstopredictgramnegativebacteriainpatientswithupperextremityinfections